Match!

A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.

Published on May 1, 1999in Gynecologic Oncology4.393
· DOI :10.1006/gyno.1999.5387
Alexander Sedlis24
Estimated H-index: 24
(SUNY Downstate Medical Center),
Brian N. Bundy31
Estimated H-index: 31
(Roswell Park Cancer Institute)
+ 3 AuthorsRichard J. Zaino54
Estimated H-index: 54
(Penn State Milton S. Hershey Medical Center)
Abstract
Abstract Objective. The objective of this study was to evaluate the benefits and risk of adjuvant pelvic radiotherapy aimed at reducing recurrence in women with Stage IB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy. Methods. Two hundred seventy-seven eligible patients were entered with at least two of the following risk factors: >1/3 stromal invasion, capillary lymphatic space involvement, and large clinical tumor diameter. Of 277 patients, 137 were randomized to pelvic radiotherapy (RT) and 140 to no further treatment (NFT). Results. Twenty-one (15%) in the RT group and 39 (28%) in the NFT group had a cancer recurrence, 18 of whom were vaginal/pelvic in the RT and 27 in the NFT group. In the RT group, of 18 (13%) who died, 15 died of cancer. In the NFT group, of the 30 (21%) who died, 25 died from cancer. Life table analysis indicated a statistically significant (47%) reduction in risk of recurrence (relative risk=0.53, P = 0.008, one-tail) among the RT group, with recurrence-free rates at 2 years of 88% versus 79% for the RT and NFT groups, respectively. Severe or life-threatening (Gynecologic Oncology Group grade 3 or 4) urologic adverse effects occurred in 4 (3.1%) in the RT group and 2 (1.4%) in the NFT group; 3 (2.3%) and 1 (0.7%) hematologic; 4 (3.1%) and 0 gastrointestinal (GI); and 1 (0.8%) and 0 neurologic, respectively. One patient's death was attributable to grade 4 GI adverse effects. Conclusions. Adjuvant pelvic radiotherapy following radical surgery reduces the number of recurrences in women with Stage IB cervical cancer at the cost of 6% grade 3/4 adverse events versus 2.1% in the NFT group.
  • References (24)
  • Citations (632)
📖 Papers frequently viewed together
209 Citations
258 Citations
296 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References24
Newest
#1Patricia J. Eifel (University of Texas MD Anderson Cancer Center)H-Index: 55
#2Mitchell Morris (University of Texas MD Anderson Cancer Center)H-Index: 47
Last. Mary Jane Oswald (University of Texas MD Anderson Cancer Center)H-Index: 29
view all 4 authors...
Purpose: To define the influence of tumor size and morphology on rates of central tumor control (CTC), pelvic tumor control (PTC), and disease-specific survival (DSS) in patients treated with radiotherapy for squamous cell carcinoma of the intact uterine cervix. Methods and Materials: Records of 1526 patients treated with radiotherapy for FIGO Stage IB squamous cell carcinoma of the intact uterine cervix between 1960 and 1989 were retrospectively reviewed. The maximum tumor or cervical diameter ...
212 CitationsSource
Preface. 1. Introduction: Distributions and Inference for Categorical Data. 1.1 Categorical Response Data. 1.2 Distributions for Categorical Data. 1.3 Statistical Inference for Categorical Data. 1.4 Statistical Inference for Binomial Parameters. 1.5 Statistical Inference for Multinomial Parameters. Notes. Problems. 2. Describing Contingency Tables. 2.1 Probability Structure for Contingency Tables. 2.2 Comparing Two Proportions. 2.3 Partial Association in Stratified 2 x 2 Tables. 2.4 Extensions f...
13.4k CitationsSource
#1Richard J. Zaino (Penn State Milton S. Hershey Medical Center)H-Index: 54
#2S. Ward (Drexel University)H-Index: 1
Last. E. Frauenhofer (Penn State Milton S. Hershey Medical Center)H-Index: 1
view all 8 authors...
Disagreement persists about the superiority of Reagan and Ng's method over that of Broders' for the histologic grading of squamous carcinoma of the cervix. Uncertainty about the predictive value and reproducibility of any of the grading methods prompted a comparison of factors previously suggested as indicating the biologic behavior for cervical squamous carcinoma. One hundred ninety-five women, who were enrolled in a Gynecologic Oncology Group treatment protocol of Stage IB squamous carcinoma o...
128 CitationsSource
Abstract Consideration is given to the concern that future improvements in radiation therapy which achieve increases of local control probabilities will fail to yield gains in survival, in that the new local control patients will ultimately fail because of the development of distant metastasis. The concept is that the local failure merely represents a marker of the exceptionally malignant nature of the tumor; hence, elimination of the local tumor will not affect the ultimate outcome, viz distant...
138 CitationsSource
#1Gillian Thomas (U of T: University of Toronto)H-Index: 47
#2A.J. Dembo (U of T: University of Toronto)H-Index: 3
64 CitationsSource
#1Gregorio Delgado (Georgetown University)H-Index: 22
#2Brian N. Bundy (Gynecologic Oncology Group)H-Index: 31
Last. Francis J. Major (Anschutz Medical Campus)H-Index: 12
view all 6 authors...
Abstract There were 732 evaluable patients with primary, previously untreated, histologically confirmed stage I squamous carcinoma of the cervix with ⩾3-mm invasion. Of these, 645 had no gross disease beyond the cervix/uterus, had negative paraaortic lymph nodes, and had undergone a radical hysterectomy with pelvic lymphadenectomy. The 3-year disease-free interval (DFIs) for the 545 patients with negative pelvic nodes was 85.6%, and for the 100 with positive pelvic nodes, 74.4%. A large number o...
655 CitationsSource
When designing a clinical trial to test the equality of survival distributions for two treatment groups, the usual assumptions are exponential survival, uniform patient entry, full compliance, and censoring only administratively at the end of the trial. Various authors have presented methods for estimation of sample size or power under these assumptions, some of which allow for an R-year accrual period with T total years of study, T > R. The method of Lachin (1981, Controlled Clinical Trials 2, ...
289 CitationsSource
#1John Boyce (SUNY Downstate Medical Center)H-Index: 25
#2Rachel G. FruchterH-Index: 28
Last. Marvin Rotman (SUNY Downstate Medical Center)H-Index: 43
view all 8 authors...
Vascular invasion was identified as an important prognostic variable for all lesion sizes in 138 patients with Stage I cervical carcinoma. A matched pairs analysis, controlling for lesion size and extracervical spread, showed that vascular invasion was significantly associated with poor outcome. Regression analysis also indicated that vascular invasion contributed prognostic information beyond that available from lesion size and extracervical spread. Studies of adjunctive therapy based on the pr...
61 CitationsSource
Determination du nombre d'observations necessaires pour tester l'egalite de deux distributions de survie quand on incorpore l'information concomitante
533 CitationsSource
#1Kjell E. KjørstadH-Index: 18
Last. Torbj Rn IversenH-Index: 10
view all 3 authors...
The combination of surgery and radiotherapy for early cases of cancer of the cervix has been accused of producing prohibitive complication rates. In a series of 612 patients with cancer of the cervix, Stage IB, the frequency of major complications from the urinary and gastrointestinal tract has been studied, and an attempt has been made in determining the most probable etiology of these complications. No significant increase in complications can be attributed to the use of preoperative intracavi...
46 CitationsSource
Cited By632
Newest
Source
OBJECTIVE Few prognostic factors likely to influence therapeutic management of early-stage cervical cancer are currently recognized. The objective of this study was to determine the prognostic value of lymphovascular space invasion (LVSI) in overall survival of patients with early-stage cervical cancer. METHODS This is a retrospective study of patients treated for early-stage cervical cancer between January 1996 and December 2013 at Toulouse University Hospital and the Cancer Center Claudius Reg...
Source
#1Christen R. Elledge (JHUSOM: Johns Hopkins University School of Medicine)
#2Sushil Beriwal (University of Pittsburgh)H-Index: 33
Last. Catheryn M. Yashar (UCSD: University of California, San Diego)H-Index: 27
view all 11 authors...
Abstract Objective To develop expert consensus recommendations regarding radiation therapy for gynecologic malignancies during the COVID-19 pandemic. Methods An international committee of ten experts in gynecologic radiation oncology convened to provide consensus recommendations for patients with gynecologic malignancies referred for radiation therapy. Treatment priority groups were established. A review of the relevant literature was performed and different clinical scenarios were categorized i...
Source
#1LingYun Yang (Sichuan University)H-Index: 2
#2Jialing Yuan (Sichuan University)
Last. Wang Hj (Sichuan University)H-Index: 2
view all 5 authors...
Background: The incidence of cervical cancer in young women is rising, and squamous cell carcinoma makes up a great percentage of the histological types. The presence of aggressive pathologic risk factors following patients’ primary surgery may warrant the use of adjuvant radiotherapy. It is important to weigh up the risks and benefits of using adjuvant radiotherapy for each young patient so as to maximize their prognosis while minimizing the treatment-related morbidity. Methods: A retrospective...
Source
#1J. ContrerasH-Index: 4
#2A. Srivastava (WashU: Washington University in St. Louis)
Last. Perry W. Grigsby (WashU: Washington University in St. Louis)H-Index: 68
view all 11 authors...
OBJECTIVE Compared with 3D-planned pelvic radiation, intensity-modulated radiation therapy (IMRT) has been shown to reduce acute toxicity in cervical cancer patients after radical hysterectomy. This study evaluated late toxicity and patterns of failure after post-operative pelvic IMRT interdigitated weekly with high dose rate brachytherapy. METHODS This retrospective study included 53 cervical cancer patients treated between January 2006 and August 2019 with radical hysterectomy, lymphadenectomy...
Source
#1Roni Nitecki (University of Texas MD Anderson Cancer Center)
#2Pedro Tomas Ramirez (University of Texas MD Anderson Cancer Center)H-Index: 46
Last. Alexander Melamed (Columbia University)H-Index: 13
view all 8 authors...
Importance Minimally invasive techniques are increasingly common in cancer surgery. A recent randomized clinical trial has brought into question the safety of minimally invasive radical hysterectomy for cervical cancer. Objective To quantify the risk of recurrence and death associated with minimally invasive vs open radical hysterectomy for early-stage cervical cancer reported in observational studies optimized to control for confounding. Data Sources Ovid MEDLINE, Ovid Embase, PubMed, Scopus, a...
Source
#1Michael Frumovitz (University of Texas MD Anderson Cancer Center)H-Index: 41
#2Andreas Obermair (UQ: University of Queensland)H-Index: 48
Last. Alessandro BudaH-Index: 18
view all 20 authors...
Summary Background In the phase 3 LACC trial and a subsequent population-level review, minimally invasive radical hysterectomy was shown to be associated with worse disease-free survival and higher recurrence rates than was open radical hysterectomy in patients with early stage cervical cancer. Here, we report the results of a secondary endpoint, quality of life, of the LACC trial. Methods The LACC trial was a randomised, open-label, phase 3, non-inferiority trial done in 33 centres worldwide. E...
1 CitationsSource
#1Woo Yeon Hwang (Seoul National University Bundang Hospital)
#2J.S. Kim (Seoul National University Bundang Hospital)
Last. Yong Beom Kim (Seoul National University Bundang Hospital)H-Index: 16
view all 6 authors...
Objective Patients who undergo radical hysterectomy may require postoperative adjuvant radiotherapy, and all efforts should be made to reduce dual therapy in such patients. The aim of this study was to determine the optimal upper limit of tumor size in patients with International Federation of Gynecology and Obstetrics (FIGO) stage IB2 cervical cancer who undergo radical hysterectomy. Methods We retrospectively reviewed the records of 114 patients with FIGO 2018 stage IB2 cervical cancer who und...
Source
#1Takaya Yamamoto (Tohoku University)H-Index: 8
#2Rei Umezawa (Tohoku University)H-Index: 11
Last. Kiyokazu Sato (Tohoku University)H-Index: 6
view all 13 authors...
The purpose of this study was to reveal treatment outcomes and toxicity after pelvic intensity-modulated radiotherapy (IMRT) for postoperative uterine cervical cancer of Japanese patients. Consecutive patients who were treated with pelvic IMRT for postoperative cervical cancer in our institute were retrospectively analyzed. Relapse-free survival (RFS) and overall survival (OS) were calculated using the Kaplan-Meier estimator, and log-rank tests were used to compare differences. From the database...
Source
Abstract Purpose This guideline reviews the evidence and provides recommendations for the indications and appropriate techniques of radiation therapy (RT) in the treatment of nonmetastatic cervical cancer. Methods The American Society for Radiation Oncology convened a task force to address 5 key questions focused on the use of RT in definitive and postoperative management of cervical cancer. These questions included the indications for postoperative and definitive RT, the use of chemotherapy in ...
Source